Neurologic Imaging

What Imaging Is Best for Persistent Hyperparathyroidism After Surgery?

·
What Imaging Is Best for Persistent Hyperparathyroidism After Surgery?

A 58-year-old patient returns to the endocrinology clinic six months after a parathyroidectomy for primary hyperparathyroidism. Despite the surgery, their serum calcium and parathyroid hormone (PTH) levels remain elevated. The surgeon is planning a re-exploration but needs precise localization of the presumed residual or ectopic parathyroid tissue to minimize operative time and risk in a previously dissected neck. You are tasked with ordering the initial imaging for this challenging clinical problem. This article details the ACR-guided workflow for recurrent or persistent primary hyperparathyroidism, where multiple advanced imaging modalities, including Ultrasound, Sestamibi SPECT/CT, and 4D-CT, are considered `Usually appropriate` to guide re-operation.

Who Fits This Clinical Scenario?

This guidance applies to a specific and challenging patient population: adults or children with biochemically confirmed primary hyperparathyroidism (elevated or inappropriately normal PTH in the setting of hypercalcemia) who have persistent or recurrent disease after at least one parathyroid surgery. The key feature is the history of prior neck exploration, which introduces scar tissue and altered anatomy, complicating both imaging interpretation and subsequent surgery.

This workflow is not intended for:

  • Initial Diagnosis of Primary Hyperparathyroidism: Patients who have not yet undergone surgery have a different set of imaging considerations. Their anatomy is undisturbed, which influences the performance and choice of initial studies. This is a distinct clinical scenario.
  • Secondary or Tertiary Hyperparathyroidism: These conditions, typically seen in patients with chronic kidney disease, involve different pathophysiology (usually multigland hyperplasia) and have their own dedicated imaging guidelines.
  • Incidentally Discovered Neck Mass: A patient with a neck mass found on other imaging but without the corresponding biochemical evidence of hyperparathyroidism does not fit this scenario. The workup for such a finding follows a different diagnostic pathway.

What Diagnoses Are You Working Up in This Scenario?

When hyperparathyroidism persists after surgery, the goal of imaging is to pinpoint the source of PTH overproduction. The differential diagnosis is narrow but surgically critical, as the location of the target tissue dictates the operative approach.

Ectopic Parathyroid Adenoma is the most common cause of persistent or recurrent primary hyperparathyroidism. During embryologic development, parathyroid glands migrate from the third and fourth pharyngeal pouches. An adenoma can arise anywhere along this path, from the angle of the jaw down to the mediastinum. Common ectopic locations include retroesophageal, within the carotid sheath, intrathymic, or even inside the thyroid gland itself. These are, by definition, difficult to find during a standard initial neck exploration.

Missed Orthotopic Adenoma or Supernumerary Gland is another significant possibility. A surgeon may have removed one enlarged gland, but a second, smaller adenoma in a normal (orthotopic) position was overlooked. Less commonly, a patient may have a fifth parathyroid gland (a supernumerary gland) that has become adenomatous and was not identified during the initial procedure.

Multigland Disease or Hyperplasia can also lead to surgical failure. If the patient’s condition was caused by four-gland hyperplasia rather than a single adenoma, removing only the most enlarged gland will not cure the hyperparathyroidism. The remaining hyperplastic glands will continue to overproduce PTH.

Parathyroid Carcinoma is a rare but important consideration, especially in cases of severe hypercalcemia and very high PTH levels. While uncommon, its potential for local invasion and metastasis makes preoperative identification crucial for planning a more extensive en-bloc resection.

Why Advanced Imaging Is Usually Appropriate for This Presentation

In the setting of a re-operative neck, localization is paramount, and the ACR guidelines reflect this by rating multiple advanced imaging modalities as `Usually appropriate`. While neck ultrasound is a mainstay for initial diagnosis, its utility is often diminished after surgery. The surgically altered anatomy, scar tissue, and fibrosis can obscure a residual adenoma, significantly reducing the sensitivity of ultrasound. For this reason, functional and high-resolution cross-sectional imaging often take center stage.

The two most powerful and frequently used modalities in this scenario are:

  • Sestamibi SPECT/CT: This nuclear medicine study is rated `Usually appropriate` and combines functional and anatomic imaging. The Sestamibi radiotracer is preferentially taken up by hyperfunctioning parathyroid tissue. Fusing the single-photon emission computed tomography (SPECT) data with a low-dose CT provides a precise 3D map, showing exactly where the “hot” spot of tracer uptake is located anatomically. This is exceptionally valuable for identifying ectopic glands in the chest (mediastinum) or in other unexpected locations. This study involves a radiation dose of ☢☢☢ 1-10 mSv.
  • CT Neck Without and With IV Contrast (4D-CT): Also rated `Usually appropriate`, this is a specialized dynamic CT protocol. It involves acquiring non-contrast, arterial, and delayed venous phase images through the neck and upper chest. Parathyroid adenomas typically demonstrate avid arterial enhancement and rapid washout on delayed phases—a distinct vascular signature. This technique provides exquisite anatomic detail, which is critical for surgical planning in a scarred operative field. The radiation dose is ☢☢☢ 1-10 mSv for adults and can be ☢☢☢☢ 3-10 mSv for pediatric protocols.

In contrast, some studies are less helpful. For example, an MRI neck without IV contrast is rated `Usually not appropriate`. While it provides excellent soft tissue detail and avoids ionizing radiation (O 0 mSv), it lacks the specific functional information of a Sestamibi scan and the characteristic enhancement pattern seen on 4D-CT, making it difficult to confidently identify and distinguish a parathyroid adenoma from other structures like lymph nodes in a post-surgical neck.

What’s Next After Imaging? Downstream Workflow

The results of these localization studies directly guide the next steps, which almost always involve a multidisciplinary discussion between the endocrinologist, radiologist, and surgeon.

  • If studies are positive and concordant: This is the ideal outcome. For instance, if both a 4D-CT and a Sestamibi SPECT/CT identify a lesion in the same location (e.g., retroesophageal space), there is high confidence in the target. The surgeon can plan a focused, minimally invasive re-operation directed at that specific site, minimizing dissection in the scarred neck.
  • If studies are negative: If high-quality 4D-CT and Sestamibi SPECT/CT are both negative, it presents a significant challenge. This may prompt consideration of more invasive diagnostic procedures. Venous sampling for parathyroid hormone, rated `May be appropriate`, may be considered. This interventional radiology procedure involves catheterizing the small veins draining the neck and thyroid and measuring PTH levels to regionalize the source of hormone excess, even if it cannot be visualized.
  • If studies are positive but discordant: When one study identifies a potential lesion but another does not, or they point to different locations, careful review is required. The team must weigh the evidence, consider the strengths and weaknesses of each modality, and decide on the most likely culprit. In some cases, a third imaging modality like an MRI (rated `May be appropriate` with contrast) might be used to provide additional soft tissue characterization before proceeding with surgery.

Ultimately, the goal is to provide the surgeon with a clear, unambiguous target before re-entering a complex operative field.

Pitfalls to Avoid (and When to Get Help)

Navigating the workup for persistent hyperparathyroidism requires careful attention to detail to avoid common errors.

  • Relying solely on ultrasound: Do not assume a negative ultrasound in a post-operative neck rules out an adenoma. Scar tissue severely limits its sensitivity.
  • Ordering a standard neck CT: A routine “CT neck with contrast” is not the same as a 4D-CT. The specific multiphasic protocol is essential for identifying the characteristic vascular pattern of an adenoma. Be explicit when ordering.
  • Ignoring the original operative report: The surgeon’s notes from the initial operation are invaluable. They detail which glands were identified and removed, and which were not, providing crucial clues for where to look.
  • Failing to consider the mediastinum: Ensure the imaging field of view for both CT and Sestamibi extends inferiorly to cover the entire mediastinum, a common hiding place for ectopic glands.

If high-quality, noninvasive localization studies are negative or equivocal, it is time to escalate. This is the point to engage an experienced head and neck or endocrine surgeon and a radiologist at a high-volume center for a multidisciplinary case review and to consider advanced procedures like selective venous sampling.

Related ACR Topics and Tools

For a comprehensive overview of all clinical variants related to parathyroid adenoma imaging, please consult our parent topic hub article. It provides a breadth of information that complements this in-depth look at a single, complex scenario.

Frequently Asked Questions

Why are both 4D-CT and Sestamibi SPECT/CT considered ‘Usually Appropriate’ in this scenario?

In the re-operative setting, localization is extremely challenging due to scar tissue. 4D-CT provides superior anatomic detail and vascular information, while Sestamibi SPECT/CT provides functional data (hormone production). They are complementary, and using both often increases the confidence of localization before a difficult surgery. Concordant findings on both studies are the strongest predictor of a successful re-operation.

Is an MRI a good alternative to CT to avoid radiation?

While an MRI with and without contrast is rated ‘May be appropriate,’ it is generally not a first-line choice in this scenario. It lacks the specific dynamic enhancement information of 4D-CT and the functional data of a Sestamibi scan. An MRI without contrast is considered ‘Usually not appropriate.’ The diagnostic benefit of localizing the adenoma with CT or SPECT/CT is generally felt to outweigh the risk from the moderate radiation dose.

What if all noninvasive imaging is negative?

If high-quality 4D-CT and Sestamibi SPECT/CT are both negative in a patient with confirmed persistent hyperparathyroidism, the next step is often selective venous sampling. This invasive procedure can help lateralize or regionalize the source of the excess PTH, guiding the surgeon to a specific area of the neck or chest even when no lesion is visible on imaging.

Does this guidance apply to a patient who had surgery years ago and is now hypercalcemic again?

Yes. This scenario covers both ‘persistent’ disease (hypercalcemia that never resolved after surgery) and ‘recurrent’ disease (hypercalcemia that resolved and then returned months or years later). The imaging approach is the same, as the primary challenge in both cases is identifying residual or ectopic parathyroid tissue in a previously operated field.

Should I order a PET scan for this workup?

While some research is exploring advanced PET tracers like 18F-Choline for parathyroid imaging, it is not currently part of the standard ACR Appropriateness Criteria for this scenario. The established and recommended modalities are 4D-CT and Sestamibi SPECT/CT. PET scans are considered investigational for this indication at present.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 29, 2026